SEC Form D · filed July 10, 2024
Checkpoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Christian F. Bechon · Waltham, MADirectorNeil F. Herskowitz · Waltham, MADirectorJames F. Oliviero, Iii · Waltham, MAExec · DirectorGarrett F. Gray · Waltham, MAExecLindsay A. Rosenwald · Waltham, MADirectorMichael F. Weiss · Waltham, MADirectorBarry F. Salzman · Waltham, MADirectorMarco M. Buhigas Moran · Madrid, U3Exec · DirectorAshley Mayer · Dover, DEDirectorBarbara Serrano Sanchez · Madrid, U3DirectorToyin Ajayi · Dover, DEDirectorStuart Orgill · San Francisco, CAExecJose M. Moran Adarraga · Madrid, U3DirectorManuel E. Tarrasa Sanchez · Madrid, U3DirectorAmit A. Sharma · Waltham, MADirectorDavid Carew · Toronto, Ontario, CanadaExec · DirectorMaxim D. Crewe · London, United KingdomExecThomas P. Railhac · London, United KingdomDirectorSven Gosta P. Pattersson · London, United KingdomDirectorHiroaki Kobayashi · BALTIMORE, MDDirectorJeffrey Cleland · BALTIMORE, MDDirectorAkihiro Ko · BALTIMORE, MDDirectorAmit A. Sharma · Waltham, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗